Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Jinbin Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5122-7502; OpenAlex author ID A5046984653. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 3

  1. Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts. Last author DOI 10.1177/15330338211036324↗
  2. Pyrrolidine Dithiocarbamate Facilitates Arsenic Trioxide Against Pancreatic Cancer via Perturbing Ubiquitin-Proteasome Pathway. Last author DOI 10.2147/cmar.s278674↗
  3. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenograf… Co-author DOI 10.1016/j.taap.2013.09.009↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Renyan Tang · 1 shared paper, 2021 · strength 0.17
  2. Ying Liu · 1 shared paper, 2021 · strength 0.17
  3. Simin Yu · 1 shared paper, 2020 · strength 0.15
  4. Yong-Qiang Hua · 1 shared paper, 2013 · strength 0.04
  5. Weidong Shi · 1 shared paper, 2013 · strength 0.04
  6. Luming Liu · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.